why choose us

First received: November 07, 2023

Clinical Trial: Dexamethasone Eluting Cochlear Implant: a Pivotal Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cochlear Implant

Study Type: INTERVENTIONAL


Official Title: Dexamethasone-Eluting Cochlear Implant Electrode (CIDEXEL): Pivotal Study

Brief Summary: The newly developed MED-EL Cochlear Implant Mi1250 +FLEX28 DEX (CIDEXEL) incorporates the anti-inflammatory agent dexamethasone (DEX) into the electrode array. The passive elution of DEX during the post-implantation period has the purpose of counteracting the increase of the post-operative impedance induced by the insertion trauma.The aim of this clinical investigation is to obtain confirmatory data concerning safety and performances of the investigational device in the clinical population.

Read more